Functional plasticity of macrophages: In situ reprogramming of tumor-associated macrophages

Journal of Leukocyte Biology

Volumn 86, Issue 5, 2009, Pages 1105-1109

  Stout, Robert D ^a   Watkins, Stephanie K ^b   Suttles, Jill ^a  

^a University of Louisville School of Medicine   (United States)

^b NATIONAL CANCER INSTITUTE   (United States)

Author keywords

Cancer; IL 12; Inflammation; Macrophage subsets

Indexed keywords

INTERLEUKIN 12; LIPID; MICROSPHERE;

ADAPTIVE IMMUNITY; CANCER IMMUNOTHERAPY; CELL DIFFERENTIATION; CELL FUNCTION; CELL HETEROGENEITY; CELL LINEAGE; CHRONIC INFLAMMATION; GENE MUTATION; HYPOTHESIS; IMMUNE SYSTEM; MACROPHAGE; METASTASIS; MICROENVIRONMENT; NEOPLASM; NONHUMAN; PHENOTYPE; PLASTICITY; POLARIZATION; PRIORITY JOURNAL; SHORT SURVEY; SIGNAL TRANSDUCTION; TUMOR; TUMOR ASSOCIATED LEUKOCYTE; TUMOR GROWTH;

CELL DIFFERENTIATION; HUMANS; IMMUNE SYSTEM; KILLER CELLS, NATURAL; MACROPHAGES; MONOCYTES; NEOPLASMS; TH1 CELLS; TH2 CELLS;

EID: 70350529527     PISSN: 07415400     EISSN: None     Source Type: Journal    
DOI: 10.1189/jlb.0209073     Document Type: Short Survey

References (64)

1. Stout, R. D., Suttles, J. (2004) Functional plasticity of macrophages: reversible adaptation to changing microenvironments. J. Leukoc. Biol. 76, 509-513.
2. Gordon, S., Taylor, P. R. (2005) Monocyte and macrophage heterogeneity. Nat. Rev. Immunol. 5, 953-964.
3. Goerdt, S., Politz, O., Schledzewski, K., Birk, R., Gratchev, A., Guillot, P., Hakiy, N., Klemke, C. D., Dippel, E., Kodelja, V., Orfanos, C. E. (1999) Alternative versus classical activation of macrophages. Pathobiology 67, 222-226. (Pubitemid 30135909)
4. Martinez, F. O., Sica, A., Mantovani, A., Locati, M. (2008) Macrophage activation and polarization. Front. Biosci. 13, 453-461.
5. Mosser, D. M. (2003) The many faces of macrophage activation. J. Leukoc. Biol. 73, 209-212.
6. Laskin, D. L., Weinberger, B., Laskin, J. D. (2001) Functional heterogeneity in liver and lung macrophages. J. Leukoc. Biol. 70, 163-170. (Pubitemid 32751506)
7. Guillemin, G. J., Brew, B. J. (2004) Microglia, macrophages, perivascular macrophages, and pericytes: a review of function and identification. J. Leukoc. Biol. 75, 388-397.
8. Raz, E. (2007) Organ-specific regulation of innate immunity. Nat. Immunol. 8, 3-4.
9. Stout, R. D., Suttles, J. (2005) Immunosenescence and macrophage functional plasticity: dysregulation of macrophage function by age-associated microenvironmental changes. Immunol. Rev. 205, 60-71.
10. Becher, B., Antel, J. P. (1996) Comparison of phenotypic and functional properties of immediately ex vivo and cultured human adult microglia. Glia 18, 1-10. (Pubitemid 26369596)
11. Heasman, S. J., Giles, K. M., Ward, C., Rossi, A. G., Haslett, C., Dransfield, I. (2003) Glucocorticoid-mediated regulation of granulocyte apoptosis and macrophage phagocytosis of apoptotic cells: implications for the resolution of inflammation. J. Endocrinol. 178, 29-36. (Pubitemid 36927006)
12. O'Shea, J. J., Murray, P. J. (2008) Cytokine signaling modules in inflammatory responses. Immunity 28, 477-487.
13. Diegelmann, R. F., Evans, M. C. (2004) Wound healing: an overview of acute, fibrotic and delayed healing. Front. Biosci. 9, 283-289. (Pubitemid 38925460)
14. Porcheray, F., Viaud, S., Rimaniol, A. C., Leone, C., Samah, B., Reuddre-Bosquet, N., Dormont, D., Gras, G. (2005) Macrophage activation switching: an asset for the resolution of inflammation. Clin. Exp. Immunol. 142, 481-489. (Pubitemid 41719844)
15. Schreiber, R. D. (1984) Identification of γ-interferon as a murine macrophage-activating factor for tumor cytotoxicity. Contemp. Top. Immunobiol. 13, 171-198.
16. Gordon, S. (2003) Alternative activation of macrophages. Nat. Rev. Immunol. 3, 23-35.
17. Mills, C. D., Kincaid, K., Alt, J. M., Heilman, M. J., Hill, A. M. (2000) M-1/M-2 macrophages and the Th1/Th2 paradigm. J. Immunol. 164, 6166-6173.
18. Lang, R., Patel, D., Morris, J. J., Rutschman, R. L., Murray, P. J. (2002) Shaping gene expression in activated and resting primary macrophages by IL-10. J. Immunol. 169, 2253-2263. (Pubitemid 34920965)
19. Williams, L., Jarai, G., Smith, A., Finan, P. (2002) IL-10 expression profiling in human monocytes. J. Leukoc. Biol. 72, 800-809. (Pubitemid 36277852)
20. Bogdan, C., Nathan, C. (1993) Modulation of macrophage function by transforming growth factor β, interleukin-4, and interleukin-10. Ann. N. Y. Acad. Sci. 685, 713-739. (Pubitemid 23238554)
21. Gratchev, A., Kzhyshkowska, J., Utikal, J., Goerdt, S. (2005) Interleukin-4 and dexamethasone counterregulate extracellular matrix remodeling and phagocytosis in type-2 macrophages. Scand. J. Immunol. 61, 10-17. (Pubitemid 40188343)
22. Varga, G., Ehrchen, J., Tsianakas, A., Tenbrock, K., Rattenholl, A., Seeliger, S., Mack, M., Roth, J., Sunderkoetter, C. (2008) Glucocorticoids induce an activated, anti-inflammatory monocyte subset in mice that resembles myeloid-derived suppressor cells. J. Leukoc. Biol. 84, 644-650.
23. Lee, J., Mo, J. H., Katakura, K., Alkalay, I., Rucker, A. N., Liu, Y. T., Lee, H. K., Shen, C., Cojocaru, G., Shenouda, S., Kagnoff, M., Eckmann, L., Ben-Neriah, Y., Raz, E. (2006) Maintenance of colonic homeostasis by distinctive apical TLR9 signaling in intestinal epithelial cells. Nat. Cell Biol. 8, 1327-1336. (Pubitemid 44835107)
24. Hu, X., Chen, J., Wang, L., Ivashkiv, L. B. (2007) Crosstalk among Jak-STAT, Toll-like receptor, and ITAM-dependent pathways in macrophage activation. J. Leukoc. Biol. 82, 237-243. (Pubitemid 47230632)
25. Wells, C. A., Chalk, A. M., Forrest, A., Taylor, D., Waddell, N., Schroder, K., Himes, S. R., Faulkner, G., Lo, S., Kasukawa, T., Kawaji, H., Kai, C., Kawai, J., Katayama, S., Carninci, P., Hayashizaki, Y., Hume, D. A., Grimmond, S. M. (2006) Alternate transcription of the Toll-like receptor signaling cascade. Genome Biol. 7, R10. (Pubitemid 43871859)
26. Vogel, S. N., Fitzgerald, K. A., Fenton, M. J. (2003) TLRs: differential adapter utilization by Toll-like receptors mediates TLR-specific patterns of gene expression. Mol. Interv. 3, 466-477.
27. Bezbradica, J. S., Medzhitov, R. (2009) Integration of cytokine and heterologous receptor signaling pathways. Nat. Immunol. 10, 333-339.
28. Ivashkiv, L. B. (2009) Cross-regulation of signaling by ITAM-associated receptors. Nat. Immunol. 10, 340-347.
29. Wilson, N. S., Dixit, V., Ashkenazi, A. (2009) Death receptor signal transducers: nodes of coordination in immune signaling networks. Nat. Immunol. 10, 348-355.
30. Sag, D., Carling, D., Stout, R. D., Suttles, J. (2008) Adenosine 5′-monophosphate-activated protein kinase promotes macrophage polarization to an anti-inflammatory functional phenotype. J. Immunol. 181, 8633-8641.
31. Martin, M., Rehani, K., Jope, R. S., Michalek, S. M. (2005) Toll-like receptor-mediated cytokine production is differentially regulated by glycogen synthase kinase 3. Nat. Immunol. 6, 777-784. (Pubitemid 43090463)
32. Qin, H., Roberts, K. L., Niyongere, S. A., Cong, Y., Elson, C. O., Benveniste, E. N. (2007) Molecular mechanism of lipopolysaccharide-induced SOCS-3 gene expression in macrophages and microglia. J. Immunol. 179, 5966-5976.
33. Benveniste, E. N., Qin, H. (2007) Type I interferons as anti-inflammatory mediators. Sci. STKE 2007, pe70.
34. Stout, R. D., Jiang, C., Matta, B., Tietzel, I., Watkins, S. K., Suttles, J. (2005) Macrophages sequentially change their functional phenotype in response to changes in microenvironmental influences. J. Immunol. 175, 342-349. (Pubitemid 40884337)
35. D'Andrea, A., Ma, X., Aste Amezaga, M., Paganin, C., Trinchieri, G. (1995) Stimulatory and inhibitory effects of interleukin (IL)-4 and IL-13 on the production of cytokines by human peripheral blood mononuclear cells: priming for IL-12 and tumor necrosis factor α production. J. Exp. Med. 181, 537-546.
36. Masli, S., Turpie, B. (2009) Anti-inflammatory effects of tumor necrosis factor (TNF)-α are mediated via TNF-R2 (p75) in tolerogenic transforming growth factor-β-treated antigen-presenting cells. Immunology 127, 62-72.
37. Brem-Exner, B. G., Sattler, C., Hutchinson, J. A., Koehl, G. E., Kronenberg, K., Farkas, S., Inoue, S., Blank, C., Knechtle, S. J., Schlitt, H. J., Fandrich, F., Geissler, E. K. (2008) Macrophages driven to a novel state of activation have anti-inflammatory properties in mice. J. Immunol. 180, 335-349.
38. Niho, Y., Niiro, H., Tanaka, Y., Nakashima, H., Otsuka, T. (1998) Role of IL-10 in the crossregulation of prostaglandins and cytokines in monocytes. Acta Haematol. 99, 165-170. (Pubitemid 28154562)
39. Dace, D. S., Khan, A. A., Kelly, J., Apte, R. S. (2008) Interleukin-10 promotes pathological angiogenesis by regulating macrophage response to hypoxia during development. PLoS ONE 3, e3381.
40. Jacobs, F., Chaussabel, D., Truyens, C., Leclerq, V., Carlier, Y., Goldman, M., Vray, B. (1998) IL-10 up-regulates nitric oxide (NO) synthesis by lipopolysaccharide (LPS)-activated macrophages: improved control of Trypanosoma cruzi infection. Clin. Exp. Immunol. 113, 59-64. (Pubitemid 28329066)
41. Pulichino, A. M., Wang, I. M., Caron, A., Mortimer, J., Auger, A., Boie, Y., Elias, J. A., Kartono, A., Xu, L., Menetski, J., Sayegh, C. E. (2008) Identification of transforming growth factor β1-driven genetic programs of acute lung fibrosis. Am. J. Respir. Cell Mol. Biol. 39, 324-336.
42. Li, G., Abediankenari, S., Kim, Y. J., Campbell, T. B., Ito, S., Graham-Evans, B., Cooper, S., Broxmeyer, H. E. (2007) TGF-β combined with M-CSF and IL-4 induces generation of immune inhibitory cord blood dendritic cells capable of enhancing cytokine-induced ex vivo expansion of myeloid progenitors. Blood 110, 2872-2879. (Pubitemid 350006940)
43. Umemura, N., Saio, M., Suwa, T., Kitoh, Y., Bai, J., Nonaka, K., Ouyang, G. F., Okada, M., Balazs, M., Adany, R., Shibata, T., Takami, T. (2008) Tumor-infiltrating myeloid-derived suppressor cells are pleiotropic-inflamed monocytes/macrophages that bear M1- and M2-type characteristics. J. Leukoc. Biol. 83, 1136-1144. (Pubitemid 351960345)
44. Stout, R. D., Suttles, J. (1995) T cell signaling of macrophage activation. In Cell Contact-Dependent and Cytokine Signals, Austin, TX, USA, R. G. Landes Co.; Springer-Verlag.
45. Adams, D. O., Hamilton, T. A. (1992) Molecular basis of macrophage activation: diversity and its origins. In The Macrophage (C. E. Lewis, J. O. McGee, eds.), Oxford, UK, Oxford University Press, 75-114.
46. Singer, A. J., Clark, R. A. (1999) Cutaneous wound healing. N. Engl. J. Med. 341, 738-746.
47. Barnes, P. J. (2004) Alveolar macrophages as orchestrators of COPD. COPD 1, 59-70.
48. Houghton, A. M., Mouded, M., Shapiro, S. D. (2008) Common origins of lung cancer and COPD. Nat. Med. 14, 1023-1024.
49. van der Bij, G. J., Oosterling, S. J., Meijer, S., Beelen, R. H., van Egmond, M. (2005) The role of macrophages in tumor development. Cell Oncol. 27, 203-213.
50. Condeelis, J., Pollard, J. W. (2006) Macrophages: obligate partners for tumor cell migration, invasion, and metastasis. Cell 124, 263-266. (Pubitemid 43121975)
51. Lewis, C. E., Pollard, J. W. (2006) Distinct role of macrophages in different tumor microenvironments. Cancer Res. 66, 605-612. (Pubitemid 43165918)
52. Watkins, S. K., Egilmez, N. K., Suttles, J., Stout, R. D. (2007) IL-12 rapidly alters the functional profile of tumor-associated and tumor-infiltrating macrophages in vitro and in vivo. J. Immunol. 178, 1357-1362. (Pubitemid 46154605)
53. Elgert, K. D., Alleva, D. G., Mullins, D. W. (1998) Tumor-induced immune dysfunction: the macrophage connection. J. Leukoc. Biol. 64, 275-290.
54. Serafini, P., Borrello, I., Bronte, V. (2006) Myeloid suppressor cells in cancer: recruitment, phenotype, properties, and mechanisms of immune suppression. Semin. Cancer Biol. 16, 53-65. (Pubitemid 43139709)
55. Valenti, R., Huber, V., Iero, M., Filipazzi, P., Parmiani, G., Rivoltini, L. (2007) Tumor-released microvesicles as vehicles of immunosuppression. Cancer Res. 67, 2912-2915.
56. Rosenberg, S. A., Yang, J. C., Restifo, N. P. (2004) Cancer immunotherapy: moving beyond current vaccines. Nat. Med. 10, 909-915. (Pubitemid 39273730)
57. Tsung, K., Dolan, J. P., Tsung, Y. L., Norton, J. A. (2002) Macrophages as effector cells in interleukin 12-induced T cell-dependent tumor rejection. Cancer Res. 62, 5069-5075. (Pubitemid 34984436)
58. Guiducci, C., Vicari, A. P., Sangaletti, S., Trinchieri, G., Colombo, M. P. (2005) Redirecting in vivo elicited tumor infiltrating macrophages and dendritic cells towards tumor rejection. Cancer Res. 65, 3437-3446. (Pubitemid 40524630)
59. Buhtoiarov, I. N., Lum, H., Berke, G., Paulnock, D. M., Sondel, P. M., Rakhmilevich, A. L. (2005) CD40 ligation activates murine macrophages via an IFN-γ-dependent mechanism resulting in tumor cell destruction in vitro. J. Immunol. 174, 6013-6022. (Pubitemid 40663788)
60. Buhtoiarov, I. N., Lum, H. D., Berke, G., Sondel, P. M., Rakhmilevich, A. L. (2006) Synergistic activation of macrophages via CD40 and TLR9 results in T cell independent antitumor effects. J. Immunol. 176, 309-318. (Pubitemid 43023276)
61. Trinchieri, G. (1995) Interleukin-12: a proinflammatory cytokine with immunoregulatory functions that bridge innate resistance and antigen-specific adaptive immunity. Annu. Rev. Immunol. 13, 251-276.
62. Hill, H. C., Conway Jr., T. F., Sabel, M. S., Jong, Y. S., Mathiowitz, E., Bankert, R. B., Egilmez, N. K. (2002) Cancer immunotherapy with interleukin 12 and granulocyte-macrophage colony-stimulating factor-encapsulated microspheres: coinduction of innate and adaptive antitumor immunity and cure of disseminated disease. Cancer Res. 62, 7254-7263. (Pubitemid 36025247)
63. Coughlin, C. M., Salhany, K. E., Wysocka, M., Aruga, E., Kurzawa, H., Chang, A. E., Hunter, C. A., Fox, J. C., Trinchieri, G., Lee, W. M. (1998) Interleukin-12 and interleukin-18 synergistically induce murine tumor regression which involves inhibition of angiogenesis. J. Clin. Invest. 101, 1441-1452. (Pubitemid 28145262)
64. Brunda, M. J., Luistro, L., Warrier, R. R., Wright, R. B., Hubbard, B. R., Murphy, M., Wolf, S. F., Gately, M. K. (1993) Antitumor and antimetastatic activity of interleukin 12 against murine tumors. J. Exp. Med. 178, 1223-1230. (Pubitemid 23277355)